These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32896462)

  • 1. Red flags in patients with hereditary transthyretin amyloidosis at diagnosis in a non-endemic area of Spain.
    Silva-Hernández L; Horga Hernández A; Valls Carbó A; Guerrero Sola A; Montalvo-Moraleda MT; Galán Dávila L
    Neurologia (Engl Ed); 2020 Sep; ():. PubMed ID: 32896462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red flags in patients with hereditary transthyretin amyloidosis at diagnosis in a non-endemic area of Spain.
    Silva-Hernández L; Horga Hernández A; Valls Carbó A; Guerrero Sola A; Montalvo-Moraleda MT; Galán Dávila L
    Neurologia (Engl Ed); 2023 Mar; 38(2):87-92. PubMed ID: 36396096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
    Adams D; Ando Y; Beirão JM; Coelho T; Gertz MA; Gillmore JD; Hawkins PN; Lousada I; Suhr OB; Merlini G
    J Neurol; 2021 Jun; 268(6):2109-2122. PubMed ID: 31907599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
    Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y
    Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Hereditary Transthyretin-Related Amyloidosis Prevalence in Crete: Genetic Heterogeneity and Distinct Phenotypes.
    Tzagournissakis M; Foukarakis E; Samonakis D; Tsilimbaris M; Michaelidou K; Mathioudakis L; Marinis A; Giannakoudakis E; Spanaki C; Skoula I; Erimaki S; Amoiridis G; Koutsis G; Koukouraki S; Stylianou K; Plaitakis A; Mitsias PD; Zaganas I
    Neurol Genet; 2022 Oct; 8(5):e200013. PubMed ID: 36101541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic screening for hereditary transthyretin amyloidosis with polyneuropathy in western Sicily: Two years of experience in a neurological clinic.
    Di Stefano V; Lupica A; Alonge P; Pignolo A; Augello SM; Gentile F; Gagliardo A; Giglia F; Brinch D; Cappello M; Di Lisi D; Novo G; Borgione E; Scuderi C; Brighina F
    Eur J Neurol; 2024 Jan; 31(1):e16065. PubMed ID: 37725003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis).
    Gonzalez-Duarte A
    Clin Auton Res; 2019 Apr; 29(2):245-251. PubMed ID: 29511897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypes of Late-Onset Transthyretin Amyloid Neuropathy: A Diagnostic Challenge.
    Živković SA; Mnatsakanova D; Lacomis D
    J Clin Neuromuscul Dis; 2019 Sep; 21(1):1-6. PubMed ID: 31453848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management.
    Alcantara M; Mezei MM; Baker SK; Breiner A; Dhawan P; Fiander A; Fine NM; Hahn C; Katzberg HD; Khayambashi S; Massie R; Matte G; Putko B; Siddiqi Z; Delgado D; Bril V
    Can J Neurol Sci; 2022 Jan; 49(1):7-18. PubMed ID: 33631091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis.
    Nie T; Heo YA; Shirley M
    Drugs; 2023 Oct; 83(15):1425-1432. PubMed ID: 37728865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Screening Identifies Individuals at High Risk for Hereditary Transthyretin Amyloidosis.
    Soper ER; Suckiel SA; Braganza GT; Kontorovich AR; Kenny EE; Abul-Husn NS
    J Pers Med; 2021 Jan; 11(1):. PubMed ID: 33467513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-Onset Hereditary Transthyretin Amyloidosis Val30Met in an Elderly Person in a Non-Endemic Area.
    Wang S; Sun J; Lu Q; Li H; Zhang Y
    Int Med Case Rep J; 2022; 15():299-306. PubMed ID: 35734096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective survey of patients with hereditary transthyretin-mediated (hATTR) amyloidosis treated with patisiran in real-world clinical practice in Belgium.
    De Bleecker JL; Claeys KG; Delstanche S; Van Parys V; Baets J; Tilleux S; Remiche G
    Acta Neurol Belg; 2023 Jun; 123(3):1029-1037. PubMed ID: 36829087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carpal tunnel syndrome and associated symptoms as first manifestation of hATTR amyloidosis.
    Karam C; Dimitrova D; Christ M; Heitner SB
    Neurol Clin Pract; 2019 Aug; 9(4):309-313. PubMed ID: 31583185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS + 7.
    Dyck PJB; González-Duarte A; Obici L; Polydefkis M; Wiesman JF; Antonino I; Litchy WJ; Dyck PJ
    J Neurol Sci; 2019 Oct; 405():116424. PubMed ID: 31445300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable Presentation of Hereditary Transthyretin-Mediated Amyloidosis at a Single Center.
    Hussain Y
    J Clin Neuromuscul Dis; 2021 Sep; 23(1):7-17. PubMed ID: 34431796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area.
    Andrés N; Poza JJ; Martí Massó JF
    Neurologia (Engl Ed); 2018; 33(9):583-589. PubMed ID: 27793437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathy.
    Conceição I; González-Duarte A; Obici L; Schmidt HH; Simoneau D; Ong ML; Amass L
    J Peripher Nerv Syst; 2016 Mar; 21(1):5-9. PubMed ID: 26663427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort.
    Pasutharnchat N; Taychargumpoo C; Vorasettakarnkij Y; Amornvit J
    BMC Neurol; 2021 May; 21(1):206. PubMed ID: 34022837
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.